YD Bio Ltd
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|
| – | +2.0% | -20.8% | +0.7% | -36.3% | -48.8% | -16.1% | +366.9% | -27.0% | |
| – | -10.5% | +30.7% | -38.0% | +1,696.2% | -93.3% | -17.8% | +4,934.4% | -42.2% | |
| – | +6.1% | +790.8% | -100.0% | +156,614,800.0% | -100.0% | +1,466.3% | +95,077.7% | -55.7% | |
| – | +6.1% | +790.8% | -100.0% | +156,614,800.0% | -100.0% | +1,466.3% | +95,077.7% | -55.7% | |
| – | +0.0% | +188.7% | +0.0% | +387.5% | -79.5% | +0.0% | +1,221.3% | -21.5% | |
| – | – | – | – | – | – | – | +403.2% | +0.7% | |
| – | – | – | – | – | – | – | -10.1% | -5.2% | |
| – | +216.8% | -51.6% | -13.4% | -98.0% | +6,017.8% | +13.4% | -12.5% | -66.4% | |
| – | +14.2% | +7.3% | +1.9% | -97.4% | +4,019.9% | +3.5% | -85.3% | -35.0% | |
| – | – | – | – | – | – | – | – | -26.0% | |
| – | – | – | – | – | – | – | +491.0% | -10.1% | |
| – | -742.3% | – | – | – | -301.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | |
| – | +0.0% | -1.8% | -4.4% | +0.0% | -15.2% | -0.3% | +1,968.4% | +0.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.